arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

Elevance Health, Inc.

ELV
$394.22 ▲ +2.78 (+0.71%) at close
Healthcare ·Hospital & Medical Service Plans ·USHospital & Medical Service Plans
75 Visible periods
34 Metrics
Peer-ranked Benchmarks
Price Chart
50
Health
Fair
Bullish
auto_awesome

Analytical Summary

Elevance Health, Inc. shows strong fundamentals with top-quartile Return on Common Equity (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $85.5B
Dividend Yield 0.44%
Revenue Growth 1.4%
Op. Margin 3.5%
ROIC 1.7%
FCF / Share $7.49
Trailing P/E 58.5x
Price / Book 1.9x
FCF Yield 1.9%
Debt / Equity 0.69
info Valuation on last close. End-of-day price, Aug 7, 2026.

75-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$50.47B
↑ +1.4%
Net Income Profit after all expenses
$1.46B
↓ -16.1%
Operating Margin Operating profit as % of sales
3.5%
↓ -16.0% 39th
FCF / Share Free cash flow per share
$7.49
↓ -59.8%
Long-Term Debt Long-term obligations
$31.04B
— -0.2%
trending_up

Bullish Indicators

  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability
37
Returns
76
Financial Health
38
Cash Quality
42

Dividend History

Dividend / share · sourced from SEC filings
$5.92 Latest / share
+15.6% YoY
+14.5% 10-yr CAGR

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 20 years · 75 quarters